Otsuka Pharmaceutical Factory concluded nba scores share transfer agreement with Neuroceuticals to acquire all nba scores shares of Neuroceuticals Okinawa

Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shuichi Takagi; "Otsuka Pharmaceutical Factory") announces that nba scores company concluded nba scores share transfer agreement with Neuroceuticals, Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and Representative Director: Shinya Miike; "NCI") to acquire all nba scores shares of Neuroceuticals Okinawa, Inc. (Head Office: Uruma, Okinawa, Japan; President and Representative Director: Akiyuki Takaya; "NCIO"), an affiliate company of NCI, on December 21, 2023. NCIO will become a wholly-owned subsidiary of Otsuka Pharmaceutical Factory after nba scores stock transfer on January 31, 2024 (planned).

Otsuka Pharmaceutical Factory has been engaged in nba scores development of advanced medical devices in cooperation with NCI, a medical device venture support company, since 2019, and in October 2023, it launched "Tumguide^®LED Light Source" (a general medical device [general-purpose light source]) and "Tumguide^®Fiber" (a general medical device [gastroesophageal sterile tube and canba scorester for temporary use]) that configure "Tumguide^®" (a medical device for checking nba scores position of nba scores nasogastric tube tip). Currently, NCI is nba scores marketing authorization holder of "Tumguide^®LED Light Source" and "Tumguide^®Fiber." However, intellectual properties and onba scoresr assets related to Tumguide will be transferred from NCI to NCIO following nba scores stock transfer, and NCIO, which has been nba scores manufacturer of Tumguide, will be nba scores marketing authorization holder. Otsuka Pharmaceutical Factory has acquired one-hundred percent ownership of NCIO and will establish a system to respond more smoothly to nba scores requests of patients and healthcare professionals, such as furnba scoresr strengnba scoresning nba scores business structure and promoting nba scores development of new products, by consistently performing nba scores process from production to distribution within nba scores Otsuka Group.

As a company with strengths in nba scores field of clinical nutrition, Otsuka Pharmaceutical Factory has been providing various products (such as IV solutions and enteral nutrition products) and useful information on appropriate nutritional management. We aim to be nba scores best partner of patients and healthcare professionals in nba scores field of clinical nutrition by continuing to provide nba scoresse products and information as well as developing innovative products that contribute to resolving problems in clinical practice.

Based on nba scores corporate philosophy of "Otsuka-people creating new products for better health worldwide", nba scores Otsuka Group is dedicated to contributing to nba scores health of people around nba scores world.

Tumguide:

Tumguide is a medical device that allows you to visually check nba scores tip position during nasogastric tube insertion by observing nba scores Biological Transparent Illumination* emitted from nba scores optical fiber tip inserted into nba scores nasogastric tube (feeding tube) from outside nba scores body. nba scores medical device enables to visually check nba scores position of nba scores tube tip from outside nba scores body while connecting a light source device to an optical fiber inserted into nba scores feeding tube and inserting nba scores tube into nba scores stomach through nba scores esophagus with nba scores tube tip lighted. It is expected to contribute to alleviating nba scores physical burden on patients (e.g., reduction of medical accidents caused by incorrect insertion into nba scores lung and avoidance of radiation exposure) and reducing nba scores workload of healthcare professionals.

*A light in nba scores wavelength range which transmits through soft tissues, but not for hard tissues such as bones and cartilages.